石四药集团：吗啉硝唑获药监局批准登记成为在上市制剂使用的原料药

Core Viewpoint - The company Shijiazhuang Pharmaceutical Group (2005.HK) has received approval from the National Medical Products Administration of China for its drug Metronidazole, which is now registered as an active pharmaceutical ingredient for use in marketed formulations [1] Group 1 - The approved drug Metronidazole is a nitroimidazole antibiotic [1] - Metronidazole is primarily used for the treatment of anaerobic bacterial infections, including appendicitis and pelvic inflammatory disease [1]